Revance Therapeutics



Ebit Cambiamento Data
AbbVie USD 5.65B 407M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Eli Lilly USD 3.7B 1.93B 2025-03
J&J USD 7.39B 2.04B 2025-03
Merck USD 5.22B 339M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
P&G USD 4.56B 1.18B 2025-03
Pacira USD 12.44M 43.69M 2025-03
Supernus Pharmaceuticals USD 48.3M 19.4M 2024-12



Revance Therapeutics - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.